Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1990 Apr 1;267(1):59–62. doi: 10.1042/bj2670059

Structural specificity for prostaglandin effects on hepatocyte glycogenolysis.

E P Brass 1, M J Garrity 1
PMCID: PMC1131243  PMID: 2158311

Abstract

Prostaglandins (PGs) are known to have effects on hepatic glucose metabolism. Some actions of PGs in intact liver systems may not involve PG effects directly at the level of the hepatocyte. To define the ability of structurally distinct prostaglandins to affect hepatocyte metabolism directly, the regulation of glycogenolysis was studied in hepatocytes isolated from male Sprague-Dawley rats. PGF and PGB2 inhibited glucagon-stimulated glycogenolysis in the hepatocyte system. Pinane thromboxane A2 (PTA2) and PGD2 had no effect on glucagon-stimulated glycogenolysis. Consistent with their inhibition of glucagon-stimulated glycogenolysis, PGF2 and PGF2 alpha inhibited glucagon-stimulated hepatocyte cyclic AMP accumulation. These actions of PGB2 and PGF2 alpha are identical with those previously reported for PGE2. Additionally, PGE2, PGF2 alpha and PGB2 inhibited glucagon-stimulated adenylate cyclase activity in purified hepatic plasma membranes. In contrast, PGF2 alpha, PGD2 and PTA2 were all without affect on basal rates of hepatocyte glycogenolysis or hepatocyte cyclic AMP content. PGE2 also inhibited glycogenolysis stimulated by the alpha-adrenergic agonist phenylephrine. Exogenous arachidonic acid was not able to reproduce the affects of PGE2 or PGF2 alpha on hepatocyte glycogenolysis, consistent with an extra-hepatocyte source of the prostaglandins in the intact liver. Thus PGE2 and PGF2 alpha act specifically to inhibit glucagon-stimulated adenylate cyclase activity. No prostaglandin tested was found to stimulate glycogenolysis. PGE2 and PGF2 alpha may represent intra-hepatic modulators of hepatocyte glucose metabolism.

Full text

PDF
59

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altin J. G., Bygrave F. L. Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. Biochem J. 1988 Feb 1;249(3):677–685. doi: 10.1042/bj2490677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Altin J. G., Dieter P., Bygrave F. L. Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. Biochem J. 1987 Jul 1;245(1):145–150. doi: 10.1042/bj2450145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Altura B. M., Altura B. T. Vascular smooth muscle and prostaglandins. Fed Proc. 1976 Oct;35(12):2360–2366. [PubMed] [Google Scholar]
  4. Balazy M., Brass E. P., Gerber J. G., Nies A. S. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. Prostaglandins. 1988 Oct;36(4):421–430. doi: 10.1016/0090-6980(88)90040-8. [DOI] [PubMed] [Google Scholar]
  5. Berry M. N., Friend D. S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol. 1969 Dec;43(3):506–520. doi: 10.1083/jcb.43.3.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brass E. P., Alford C. E., Garrity M. J. Inhibition of glucagon-stimulated cAMP accumulation and fatty acid oxidation by E-series prostaglandins in isolated rat hepatocytes. Biochim Biophys Acta. 1987 Aug 19;930(1):122–126. doi: 10.1016/0167-4889(87)90164-9. [DOI] [PubMed] [Google Scholar]
  7. Brass E. P., Beyerinck R. A., Garrity M. J. Inhibition of prostaglandin E2 catabolism and potentiation of hepatic prostaglandin E2 action in rat hepatocytes by inhibitors of oxidative metabolism. Biochem Pharmacol. 1988 Apr 1;37(7):1343–1349. doi: 10.1016/0006-2952(88)90792-7. [DOI] [PubMed] [Google Scholar]
  8. Brass E. P., Garrity M. J. Effect of E-series prostaglandins on cyclic AMP-dependent and -independent hormone-stimulated glycogenolysis in hepatocytes. Diabetes. 1985 Mar;34(3):291–294. doi: 10.2337/diab.34.3.291. [DOI] [PubMed] [Google Scholar]
  9. Brass E. P., Garrity M. J. Effect of nonsteroidal anti-inflammatory drugs on glycogenolysis in isolated hepatocytes. Br J Pharmacol. 1985 Oct;86(2):491–496. doi: 10.1111/j.1476-5381.1985.tb08919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brass E. P., Garrity M. J. Modulation of prostaglandin E2 catabolism and action by fuel substrates in rat hepatocytes. Biochim Biophys Acta. 1989 Feb 9;1010(2):233–236. doi: 10.1016/0167-4889(89)90166-3. [DOI] [PubMed] [Google Scholar]
  11. Brass E. P., Garrity M. J., Robertson R. P. Inhibition of glucagon-stimulated hepatic glycogenolysis by E-series prostaglandins. FEBS Lett. 1984 Apr 24;169(2):293–296. doi: 10.1016/0014-5793(84)80336-1. [DOI] [PubMed] [Google Scholar]
  12. Brønstad G. O., Christoffersen T. Inhibitory effect of prostaglandins on the stimulation by glucagon and adrenaline of formation of cyclic AMP in rat hepatocytes. Eur J Biochem. 1981 Jul;117(2):369–374. doi: 10.1111/j.1432-1033.1981.tb06347.x. [DOI] [PubMed] [Google Scholar]
  13. Buxton D. B., Fisher R. A., Briseno D. L., Hanahan D. J., Olson M. S. Glycogenolytic and haemodynamic responses to heat-aggregated immunoglobulin G and prostaglandin E2 in the perfused rat liver. Biochem J. 1987 Apr 15;243(2):493–498. doi: 10.1042/bj2430493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Casteleijn E., Kuiper J., Van Rooij H. C., Kamps J. A., Koster J. F., Van Berkel T. J. Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. Biochem J. 1988 Feb 15;250(1):77–80. doi: 10.1042/bj2500077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Casteleijn E., Kuiper J., van Rooij H. C., Kamps J. A., Koster J. F., van Berkel T. J. Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells. J Biol Chem. 1988 Feb 25;263(6):2699–2703. [PubMed] [Google Scholar]
  16. DeRubertis F. R., Zenser T. V., Curnow R. T. Inhibition of glucagon-mediated increases in hepatic cyclic adenosine 3', 5'-monophosphate by prostaglandin E1 and E2. Endocrinology. 1974 Jul;95(1):93–101. doi: 10.1210/endo-95-1-93. [DOI] [PubMed] [Google Scholar]
  17. Fisher R. A., Robertson S. M., Olson M. S. Stimulation of glycogenolysis and vasoconstriction in the perfused rat liver by the thromboxane A2 analogue U-46619. J Biol Chem. 1987 Apr 5;262(10):4631–4638. [PubMed] [Google Scholar]
  18. García-Sáinz J. A., Hernández-Sotomayor S. M. Stimulation of hepatic glycogenolysis by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) via cyclooxygenase products. Biochem Biophys Res Commun. 1985 Oct 15;132(1):204–209. doi: 10.1016/0006-291x(85)91008-3. [DOI] [PubMed] [Google Scholar]
  19. Garrity M. J., Brass E. P. Fasting-induced changes in prostaglandin binding in isolated hepatocytes and liver plasma membranes. Endocrinology. 1987 Mar;120(3):1134–1139. doi: 10.1210/endo-120-3-1134. [DOI] [PubMed] [Google Scholar]
  20. Garrity M. J., Brass E. P., Robertson R. P. Kinetics of prostaglandin E metabolism in isolated hepatocytes. Biochim Biophys Acta. 1984 Nov 14;796(2):136–141. doi: 10.1016/0005-2760(84)90340-0. [DOI] [PubMed] [Google Scholar]
  21. Garrity M. J., Reed M. M., Brass E. P. Coupling of hepatic prostaglandin receptors to adenylate cyclase through a pertussis toxin sensitive guanine nucleotide regulatory protein. J Pharmacol Exp Ther. 1989 Mar;248(3):979–983. [PubMed] [Google Scholar]
  22. Grinde B., Ichihara A. Effects of prostaglandins and divalent cations on cAMP production in isolated rat hepatocytes. Exp Cell Res. 1983 Oct;148(1):163–172. doi: 10.1016/0014-4827(83)90196-9. [DOI] [PubMed] [Google Scholar]
  23. Gómez-Foix A. M., Rodriguez-Gil J. E., Guinovart J. J., Bosch F. Prostaglandins E2 and F2 alpha affect glycogen synthase and phosphorylase in isolated hepatocytes. Biochem J. 1989 Jul 1;261(1):93–97. doi: 10.1042/bj2610093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Häussinger D., Stehle T., Tran-Thi T. A., Decker K., Gerok W. Prostaglandin responses in isolated perfused rat liver: Ca2+ and K+ fluxes, hemodynamic and metabolic effects. Biol Chem Hoppe Seyler. 1987 Nov;368(11):1509–1513. doi: 10.1515/bchm3.1987.368.2.1509. [DOI] [PubMed] [Google Scholar]
  25. Iwai M., Gardemann A., Püschel G., Jungermann K. Potential role for prostaglandin F2 alpha, D2, E2 and thromboxane A2 in mediating the metabolic and hemodynamic actions of sympathetic nerves in perfused rat liver. Eur J Biochem. 1988 Jul 15;175(1):45–50. doi: 10.1111/j.1432-1033.1988.tb14164.x. [DOI] [PubMed] [Google Scholar]
  26. Kuiper J., Casteleyn E., van Berkel T. J. The role of prostaglandins in endotoxin stimulated glycogenolysis in the liver. Agents Actions. 1989 Jan;26(1-2):201–202. doi: 10.1007/BF02126609. [DOI] [PubMed] [Google Scholar]
  27. Kuiper J., De Rijke Y. B., Zijlstra F. J., Van Waas M. P., Van Berkel T. J. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. Biochem Biophys Res Commun. 1988 Dec 30;157(3):1288–1295. doi: 10.1016/s0006-291x(88)81014-3. [DOI] [PubMed] [Google Scholar]
  28. Kuiper J., Zijlstra F. J., Kamps J. A., van Berkel T. J. Identification of prostaglandin D2 as the major eicosanoid from liver endothelial and Kupffer cells. Biochim Biophys Acta. 1988 Mar 25;959(2):143–152. doi: 10.1016/0005-2760(88)90025-2. [DOI] [PubMed] [Google Scholar]
  29. Melien O., Winsnes R., Refsnes M., Gladhaug I. P., Christoffersen T. Pertussis toxin abolishes the inhibitory effects of prostaglandins E1, E2, I2 and F2 alpha on hormone-induced cAMP accumulation in cultured hepatocytes. Eur J Biochem. 1988 Mar 1;172(2):293–297. doi: 10.1111/j.1432-1033.1988.tb13886.x. [DOI] [PubMed] [Google Scholar]
  30. Okumura T., Sago T., Saito K. Effect of prostaglandins and their analogues on hormone-stimulated glycogenolysis in primary cultures of rat hepatocytes. Biochim Biophys Acta. 1988 Feb 4;958(2):179–187. doi: 10.1016/0005-2760(88)90175-0. [DOI] [PubMed] [Google Scholar]
  31. Okumura T., Sago T., Saito K. Pertussis toxin blocks an inhibition of hormone-stimulated glycogenolysis by prostaglandin E2 and its analogue in cultured hepatocytes. Prostaglandins. 1988 Oct;36(4):463–475. doi: 10.1016/0090-6980(88)90043-3. [DOI] [PubMed] [Google Scholar]
  32. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  33. Steiner A. L., Parker C. W., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972 Feb 25;247(4):1106–1113. [PubMed] [Google Scholar]
  34. Taylor W. M., Reinhart P. H., Bygrave F. L. On the role of calcium in the mechanism of action of alpha-adrenergic agonists in rat liver. Pharmacol Ther. 1983;21(1):125–141. doi: 10.1016/0163-7258(83)90070-0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES